Today on DrugResearcher.com   Beer goes flat for Kirin, splashes cash on 'ultimate cancer warrior' instead New high-res structure will boost AIDS, cancer drug development Illumina halves the cost of miRNA expression profiling Sigma-Aldrich helps siRNA N-TER cells Preclinical services news in brief

Related Industry News   DepoDur gets the nod for Australia Inhalers failing asthmatics Vitamin B12 the key to oral insulin? Inyx Pharma gets new life; Ashton awaits fate

Breaking News on Drug Discovery
Daily  Tuesday 23 October 2007		Forward to a colleague

	Product Brochure High precision optical profiling of liquid drops enhances drug discovery Whether you are characterizing the uptake of active drug substances or controlling the quality of packaging materials, contact angle provides a quick, easy and sensitive measure of quality and cleanliness in research, QC and process control... Click Here Access Full Stories Beer goes flat for Kirin, splashes cash on 'ultimate cancer warrior' instead Japan's Kirin Holdings, best-known in the West as a beer maker, will acquire a controlling stake in Kyowa Hakko, and thus get its hands on what Kyowa claims are 'the ultimate antibody warriors' against cancer... Read New high-res structure will boost AIDS, cancer drug development By solving the structure of a mammalian heat shock protein (HSP90) for the first time, a US scientist may have unlocked the door to better drugs to fight a myriad of diseases, such as AIDS, sepsis, certain cancers and Alzheimer's... Read Illumina halves the cost of miRNA expression profiling Illumina has released a new microRNA (miRNA) assay for gene expression profiling at a cost that the company believes is less than half that of other commercially available systems... Read Sigma-Aldrich helps siRNA N-TER cells Sigma-Aldrich has continued its push into siRNA delivery with the release of its N-TER nanoparticle system for hard-to-transfect cell lines... Read Preclinical services news in brief In this week's review of activity within the preclinical research services arena, new deals have emerged involving Cato Research, Genoway, Caliper Life Sciences and Rules-Based Medicine... Read
	All News Headlines for: October | September | August
	Conference & Exhibition Info Have you got problems with aching hands in your lab? Lab professionals have twice as much upper limb disorders (URLD) as employees in general. The risk of Repetitive Strain Injury (RSI) increases, when pipetting over 1.5 hours/day. The strain will also have a negative impact on the accuracy and precision. Read more..... Click Here
	Related Industry News DepoDur gets the nod for Australia Pacira Pharmaceutical's modified-release formulation of morphine has been approved for marketing in Australia by the Therapeutic Goods Administration... Read Inhalers failing asthmatics Complicated inhaler devices are failing patients according to a recent report, with tricky mechanisms and techniques resulting in low drug delivery and poor disease management... Read Vitamin B12 the key to oral insulin? Pfizer may have given up on its non-injectable insulin, but researchers in the US think they may have cracked a way to deliver the hormone orally, linking it up to vitamin B12 to protect it through the digestive... Read Inyx Pharma gets new life; Ashton awaits fate Inyx Pharma has been given a new lease on life after it was bought by another UK firm, finally bringing relief after it was dragged into administration when its US parent company Inyx Inc. ran aground financially... Read Weekly Comment 'We are not anti-Asia' says EU chemicals body There have been more calls this month to tighten regulations on pharmaceutical ingredient suppliers in the wake of the recent safety concerns emanating from low-cost regions such as China and India.  However, despite having recently established a dedicated 'China Taskforce', a major EU chemicals consortium insists that it has nothing against the region or its manufacturers. Read Previous Headlines Pfizer partners in shock after surprise Exubera exit We've all cringed at stories of people dumping their partners via text message but in the world of business, Pfizer seems to have taken things to a new level when its Exubera partners were allegedly left to find... Read Keeping sugar-free key to neuron health Scientists have discovered how neurons keep themselves sugar-free and healthy, a process that must be upheld to prevent the onset of several neurodegenerative diseases, including a fatal form of epilepsy... Read EU drug regulations not good enough, says report The European Medicines Agency is prejudiced in favour of big pharma and EU drug regulations need an overhaul, a new report says... Read Promega speeds up DNA-protein interaction analysis Promega has launched a new method of isolating the DNA sequences that bind to proteins that removes the need to generate specific antibodies used in traditional ChIP experiments... Read Viagra could cause hearing loss The earth may move and the heavens may shake but drug regulators now think Viagra could also make you go deaf... Read Technical / White Papers, Case studies, Web casts Manufacturing Variations in Polysorbate Batches - Technical / White Paper Product Information - brochures, Web centers DAICEL chiral chromatography products - Company Profile Rapid HPLC method development with ChromSword®Auto software - Product Presentation Separation of polar compounds - Application Notes Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analysis and instrumentation Assays and screening Cell culture & Equipment Chromatography Compounds and consumables Contract services (outsourcing) Drug discovery Genomics / Proteomics Informatics & IT Lab equipment & consumables Liquid handling and automation Liquid handling and sample preparation Production technologies Separation and purification

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com